Vaxart, Inc.
VXRT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $72 | $40 | $21 | $15 |
| % Growth | 82.3% | 90.3% | 37.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $72 | $40 | $21 | $15 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $76 | $50 | $31 | $23 |
| G&A Expenses | $4 | $5 | $5 | $4 |
| SG&A Expenses | $4 | $5 | $5 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $80 | $54 | $36 | $27 |
| Operating Income | -$8 | -$15 | -$15 | -$11 |
| % Margin | -10.8% | -36.8% | -71.5% | -75.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$1 | -$0 |
| Pre-Tax Income | -$8 | -$15 | -$15 | -$12 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8 | -$15 | -$16 | -$12 |
| % Margin | -11.2% | -37.7% | -74.7% | -78.9% |
| EPS | -0.04 | -0.07 | -0.068 | -0.053 |
| % Growth | 42.9% | -2.3% | -30% | – |
| EPS Diluted | -0.04 | -0.07 | -0.068 | -0.053 |
| Weighted Avg Shares Out | 229 | 228 | 228 | 228 |
| Weighted Avg Shares Out Dil | 229 | 228 | 228 | 228 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | -$5 | -$12 | -$12 | -$9 |
| % Margin | -7.5% | -30.4% | -58.7% | -57% |